129 related articles for article (PubMed ID: 24815379)
1. Application of COLD-PCR for improved detection of NF2 mosaic mutations.
Paganini I; Mancini I; Baroncelli M; Arena G; Gensini F; Papi L; Sestini R
J Mol Diagn; 2014 Jul; 16(4):393-9. PubMed ID: 24815379
[TBL] [Abstract][Full Text] [Related]
2. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
3. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis.
Sestini R; Provenzano A; Bacci C; Orlando C; Genuardi M; Papi L
Genet Test; 2008 Jun; 12(2):311-8. PubMed ID: 18554169
[TBL] [Abstract][Full Text] [Related]
4. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
Wallace AJ; Watson CJ; Oward E; Evans DG; Elles RG
Genet Test; 2004; 8(4):368-80. PubMed ID: 15684865
[TBL] [Abstract][Full Text] [Related]
5. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
7. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
[TBL] [Abstract][Full Text] [Related]
8. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
[TBL] [Abstract][Full Text] [Related]
9. Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing.
Evans DG; Hartley CL; Smith PT; King AT; Bowers NL; Tobi S; Wallace AJ; Perry M; Anup R; Lloyd SKW; Rutherford SA; Hammerbeck-Ward C; Pathmanaban ON; Stapleton E; Freeman SR; Kellett M; Halliday D; Parry A; Gair JJ; Axon P; Laitt R; Thomas O; Afridi SK; Obholzer R; ; Duff C; Stivaros SM; Vassallo G; Harkness EF; Smith MJ
Genet Med; 2020 Jan; 22(1):53-59. PubMed ID: 31273341
[TBL] [Abstract][Full Text] [Related]
10. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
Li J; Makrigiorgos GM
Biochem Soc Trans; 2009 Apr; 37(Pt 2):427-32. PubMed ID: 19290875
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.
Contini E; Paganini I; Sestini R; Candita L; Capone GL; Barbetti L; Falconi S; Frusconi S; Giotti I; Giuliani C; Torricelli F; Benelli M; Papi L
PLoS One; 2015; 10(6):e0129099. PubMed ID: 26066488
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene.
Sestini R; Vivarelli R; Balestri P; Ammannati F; Montali E; Papi L
Hum Genet; 2000 Oct; 107(4):366-71. PubMed ID: 11129337
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.
Pasmant E; Louvrier C; Luscan A; Cohen J; Laurendeau I; Vidaud M; Vidaud D; Goutagny S; Kalamarides M; Parfait B
Neurochirurgie; 2018 Nov; 64(5):335-341. PubMed ID: 26073919
[TBL] [Abstract][Full Text] [Related]
14. Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.
Xue L; He W; Zhang Y; Wang Z; Chen H; Chen Z; Zhu W; Liu D; Jia H; Jiang Y; Wang Z; Wu H
Neuro Oncol; 2022 Jun; 24(6):903-913. PubMed ID: 34918118
[TBL] [Abstract][Full Text] [Related]
15. Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis.
Evans DG; Wallace AJ; Wu CL; Trueman L; Ramsden RT; Strachan T
Am J Hum Genet; 1998 Sep; 63(3):727-36. PubMed ID: 9718334
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
Faudoa R; Xue Z; Lee F; Baser ME; Hung G
Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
[TBL] [Abstract][Full Text] [Related]
17. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
18. Mosaicism in sporadic neurofibromatosis 2 patients.
Kluwe L; Mautner VF
Hum Mol Genet; 1998 Dec; 7(13):2051-5. PubMed ID: 9817921
[TBL] [Abstract][Full Text] [Related]
19. BRAFV600E detection in melanoma is highly improved by COLD-PCR.
Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2011 May; 412(11-12):901-5. PubMed ID: 21262211
[TBL] [Abstract][Full Text] [Related]
20. Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.
Bijlsma EK; Wallace AJ; Evans DG
J Med Genet; 1997 Nov; 34(11):934-6. PubMed ID: 9391890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
